1.Banta, D, Oortwijn, W. Health technology assessment and health care in the European Union. Int J Technol Assess Health Care. 2000;16:626–635.
2.Bronzino, JD, Smith, VH, Wade, ML. Medical technology and society: An interdisciplinary perspective. Massachusetts: MIT Press; 1990.
3.Bunta, D. The development of health technology assessment. Health policy. 2003;63:121–132.
4.Chongtrakul, P, Sumpradit, N, Yoongthong W. ISafE and the evidence-based approach for essential medicines selection in Thailand. Essent Drugs Monit. 2005;34:18–19.
5.Chuengsatiansup, K, Mooksong, C. Historical of medicine and public health in Thailand. Bangkok: Society and Health Institute; 2005.
6.Green, A, Bennett, S. Sound choices: Enhancing capacity for evidence-informed health policy. Geneva: World Health Organization; 2007.
7.Hanvoravongchai, P, Letiendumrong, J, Teerawattananon, Y, Tangcharoensathien, V. Implications of private practice in private hospitals on the caesarean section rate in Thailand. Hum Resour Health Dev J. 2000;4:1–2.
8.Harris, A, Buxton, M, O'Brien, B, Rutten, F, Drummond, M. Using economic evidence in reimbursement decisions for health technologies: Experience of 4 countries. Expert Rev Pharmacoeconom Outcomes Res. 2001;1:7–12.
9.International Monetary Fund. World economic and financial surveys. Washington, DC: IMF: 2007.
10.Jindawatthana, W, Hanvoravongchai, P, Tangcharoensathien, V. High cost medical devices in Thailand: Diffusion, utilization and access. J Health Sci. 2001;10:242–252.
11.Kapol, N, Maitreemit, P, Chalongsuk, R, et al. Making health technology assessment information available for decision making: The development of a Thai database. J Med Assoc Thai. 2008;91 (supSpl 2):S8–S10.
12.Lertpitakpong, C, Chaikledkaew, U, Thavorncharoensap, M, et al. A determination of topics for health technology assessment in Thailand: Making decision makers involved. J Med Assoc Thai. 2008;91 (Suppl 2):s100–s109.
13.Mills, A. From research to knowledge to action: The dual challenge of health systems research. World Hosp Health Serv. 2004;40:18–23, 50, 51–52.
14.Ministry of Public Health of Thailand. Order of appointment from the Subcommittee for Development of the National List of Essential Medicines 3/2549. Bangkok: Ministry of Public Health of Thailand; 2006.
15.Nansunanont, S, Tantivess, S, Yothasamut, J, Putchong, C, Kongpittayachai, S. The development of health technology assessment in Thailand, 1996–2006. Nonthaburi: Health Intervention and Technology Assessment; 2008. (in Thai).
16.Neumann, P. Using cost-effectiveness analysis to improve health care: Opportunities and barriers. Oxford: Oxford University Press; 2005.
17.Office of National Statistics. Key statistics of Thailand. Bangkok: Office of National Statistics; 2005.
18.Office of the National Economic and Social Development Board. The 10th National Economic and Social Development Plan (2007–2010). Bangkok: Office of the National Economic and Social Development Board; 2007.
19.Office of the National Economic and Social Development Board. Poverty and income distribution. Bangkok: Office of the National Economic and Social Development Board.
20.Pitaknetinan, K, Tangcharoensathien, V, Supachutikul, A, Bennett, S, Mills, A. Profit, payment and pharmaceutical practices: Perspectives from hospitals in Bangkok. Health Policy. 1999;46:179–194.
21.Pitayarangsarit, S, Tangcharoensathien, V. Beyond training: Thailand experiences on sustaining capacity in health policy and systems research. Nonthaburi: International Health Policy Program. 2008.
22.Prakongsai, P, Tantivess, S, Tangcharoensathien, V. Proton radiation therapy: Is it necessary for Thailand?. Health Policy Plan J. 2002;4:8–31.
23.Tangcharoensathien, V. Social health insurance: Report of a regional expert group meeting. New Delhi: World Health Organization; 2003.
24.Tangcharoensathien, V, Harnvoravongchai, P, Pitayarangsarit, S, Kasemsup, V. Health impacts of rapid economic changes in Thailand. Soc Sci Med. 2000;51:789–807.
25.Tangcharoensathien, V, Kasemsap, V, Teerawattananon, Y, et al. Universal access to renal replacement therapy in Thailand: A policy analysis. Nonthaburi: Health Systems Research Institute; 2005.
26.Tangcharoensathien, V, Phoolcharoen, W, Pitayarangsarit, S, et al. The potential demand for an AIDS vaccine in Thailand. Health Policy. 2001;57:111–139.
27.Tangcharoensathien, V, Tantivess, S, Teerawattananon, Y, Auamkul, N, Jongudoumsuk, P. Universal coverage and its impact on reproductive health services in Thailand. Reprod Health Matters. 2002;10:59–69.
28.Tangcharoensathien, V, Vasavit, J. National health accounts in Thailand: 1994–2001. Nonthaburi: International Health Policy Program; 2004.
29.Tantivess, S, Teerawattananon, Y, Mills, A. Strengthening cost-effectiveness analysis in Thailand through the establishment of the Health Intervention and Technology Assessment Program. Pharmacoeconomics, in press.
30.Tantivess, S, Walt, G. The role of state and non-state actors in the policy process: The contribution of policy networks to the scale-up of antiretroviral therapy in Thailand. Health Policy Plan. 2008;23:328–338.
31.Teerawattananon, Y, Russell, S. A difficult balancing act: Policy actors’ perspectives on using economic evaluation to inform health-care coverage decisions under the universal health insurance coverage scheme in Thailand. Value Health. 2008;11 (Suppl 1):S52–S60.
32.Teerawattananon, Y, Russell, S, Mugford, M. Asystematic review of economic evaluation literature in Thailand: Are the data good enough to be used by policy-makers? Pharmacoeconomics. 2007;25:467–479.
33.Teerawattananon, Y, Tangcharoensathien, V. Designing a reproductive health services package in the universal health insurance scheme in Thailand: Match and mismatch of need, demand and supply. Health Policy Plan. 2004;19 (Suppl 1):i31–i39.
34.Teerawattananon, Y, Tangcharoensathien, V. Economic evaluation of the program for prevent mother-to-child HIV transmission in Thailand. Nonthaburi: Ministry of Public Health; 2002.
35.Teerawattananon, Y, Tangcharoensathien, V, Tantivess, S, Mills, A. Health sector regulation in Thailand: Recent progress and the future agenda. Health Policy. 2003;63:323–338.
36.Thai Drug System Analytical Committee. Thai drug system. Nonthaburi: The Food and Drug Administration; 2002.
37.The Drug Medical Supply Information Center (DMSIC). Prices of drugs and medical devices. Nonthaburi: The Ministry of Public Health; 2001.
38.The National Drug Committee. National list of essential medicines 2008. Nonthaburi: The Ministry of Public Health; 2008.
39.Tisayaticom, K, Patcharanarumo, W, Tangcharoensathien, V, Tiampriwan, A, Sumalee, H. SHA—Based health accounts in Asia Pacific: Country studies Thailand. Nonthaburi: International Health Policy Program; 2005.
40.Tomson, G, Sundbom, R. The technology assessment and social security in Thailand (TASSIT) project report. Stockholm: Division of International Health (IHCAR), Karolinska Institute; 1999.
41.Towse, A, Mills, A, Tangcharoensathien, V. Learning from Thailand's health reforms. BMJ. 2004;328:103–105.
42.Wells, J, Cheong-Leen, C. NICE appraisals should be everybody's business. BMJ. 2007;334:936–938.
43.Wibulpolprasert, S. The need for guidelines and the use of economic evidence in decision-making in Thailand: Lessons learnt from the development of the national list of essential drugs. J Med Assoc Thai. 2008;91 (Suppl 2):s1–s3.
44.Wibulpolprasert, S, ed. Thailand health profile: 2001–2004. Bangkok: Printing Press, Express Transportation Organization; 2005.